Chemoimmunotherapy in urothelial cancer: concurrent or sequential?

Lancet Oncol. 2021 Jul;22(7):894-896. doi: 10.1016/S1470-2045(21)00284-9. Epub 2021 May 26.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Transitional Cell*
  • Humans
  • Immunotherapy
  • Urinary Bladder Neoplasms*